List of Tables
Table 1. COVID-19 Inactivated Vaccine Market Trends
Table 2. COVID-19 Inactivated Vaccine Market Drivers & Opportunity
Table 3. COVID-19 Inactivated Vaccine Market Challenges
Table 4. COVID-19 Inactivated Vaccine Market Restraints
Table 5. Global COVID-19 Inactivated Vaccine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global COVID-19 Inactivated Vaccine Revenue Market Share by Company (2019-2024)
Table 7. Key Companies COVID-19 Inactivated Vaccine Manufacturing Base Distribution and Headquarters
Table 8. Key Companies COVID-19 Inactivated Vaccine Product Type
Table 9. Key Companies Time to Begin Mass Production of COVID-19 Inactivated Vaccine
Table 10. Global COVID-19 Inactivated Vaccine Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COVID-19 Inactivated Vaccine as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global COVID-19 Inactivated Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global COVID-19 Inactivated Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global COVID-19 Inactivated Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global COVID-19 Inactivated Vaccine Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global COVID-19 Inactivated Vaccine Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global COVID-19 Inactivated Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global COVID-19 Inactivated Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global COVID-19 Inactivated Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global COVID-19 Inactivated Vaccine Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global COVID-19 Inactivated Vaccine Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global COVID-19 Inactivated Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global COVID-19 Inactivated Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global COVID-19 Inactivated Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global COVID-19 Inactivated Vaccine Sales Value by Region (2019-2024) & (%)
Table 27. Global COVID-19 Inactivated Vaccine Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions COVID-19 Inactivated Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions COVID-19 Inactivated Vaccine Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions COVID-19 Inactivated Vaccine Sales Value, (2025-2030) & (US$ Million)
Table 31. Inovio Pharmaceuticals Basic Information List
Table 32. Inovio Pharmaceuticals Description and Business Overview
Table 33. Inovio Pharmaceuticals COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 34. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Inovio Pharmaceuticals (2019-2024)
Table 35. Inovio Pharmaceuticals Recent Developments
Table 36. Takis Biotech (Evvivax) Basic Information List
Table 37. Takis Biotech (Evvivax) Description and Business Overview
Table 38. Takis Biotech (Evvivax) COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 39. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Takis Biotech (Evvivax) (2019-2024)
Table 40. Takis Biotech (Evvivax) Recent Developments
Table 41. Zydus Cadila Basic Information List
Table 42. Zydus Cadila Description and Business Overview
Table 43. Zydus Cadila COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 44. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Zydus Cadila (2019-2024)
Table 45. Zydus Cadila Recent Developments
Table 46. Codagenix, Inc. Basic Information List
Table 47. Codagenix, Inc. Description and Business Overview
Table 48. Codagenix, Inc. COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 49. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Codagenix, Inc. (2019-2024)
Table 50. Codagenix, Inc. Recent Developments
Table 51. GeoVax, Inc. Basic Information List
Table 52. GeoVax, Inc. Description and Business Overview
Table 53. GeoVax, Inc. COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 54. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of GeoVax, Inc. (2019-2024)
Table 55. GeoVax, Inc. Recent Developments
Table 56. Bravovax Basic Information List
Table 57. Bravovax Description and Business Overview
Table 58. Bravovax COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 59. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Bravovax (2019-2024)
Table 60. Bravovax Recent Developments
Table 61. Janssen Pharmaceutical Companies Basic Information List
Table 62. Janssen Pharmaceutical Companies Description and Business Overview
Table 63. Janssen Pharmaceutical Companies COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 64. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Janssen Pharmaceutical Companies (2019-2024)
Table 65. Janssen Pharmaceutical Companies Recent Developments
Table 66. Altimmune Basic Information List
Table 67. Altimmune Description and Business Overview
Table 68. Altimmune COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 69. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Altimmune (2019-2024)
Table 70. Altimmune Recent Developments
Table 71. Vaxart Basic Information List
Table 72. Vaxart Description and Business Overview
Table 73. Vaxart COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 74. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Vaxart (2019-2024)
Table 75. Vaxart Recent Developments
Table 76. CanSino Biologics Basic Information List
Table 77. CanSino Biologics Description and Business Overview
Table 78. CanSino Biologics COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 79. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of CanSino Biologics (2019-2024)
Table 80. CanSino Biologics Recent Developments
Table 81. ExpreS2ion Biotechnologies ApS Basic Information List
Table 82. ExpreS2ion Biotechnologies ApS Description and Business Overview
Table 83. ExpreS2ion Biotechnologies ApS COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 84. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of ExpreS2ion Biotechnologies ApS (2019-2024)
Table 85. ExpreS2ion Biotechnologies ApS Recent Developments
Table 86. Clover Biopharmaceuticals Basic Information List
Table 87. Clover Biopharmaceuticals Description and Business Overview
Table 88. Clover Biopharmaceuticals COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 89. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Clover Biopharmaceuticals (2019-2024)
Table 90. Clover Biopharmaceuticals Recent Developments
Table 91. GSK Basic Information List
Table 92. GSK Description and Business Overview
Table 93. GSK COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 94. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of GSK (2019-2024)
Table 95. GSK Recent Developments
Table 96. Vaxil Bio Ltd. Basic Information List
Table 97. Vaxil Bio Ltd. Description and Business Overview
Table 98. Vaxil Bio Ltd. COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 99. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Vaxil Bio Ltd. (2019-2024)
Table 100. Vaxil Bio Ltd. Recent Developments
Table 101. Generex Basic Information List
Table 102. Generex Description and Business Overview
Table 103. Generex COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 104. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Generex (2019-2024)
Table 105. Generex Recent Developments
Table 106. Novavax, Inc. Basic Information List
Table 107. Novavax, Inc. Description and Business Overview
Table 108. Novavax, Inc. COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 109. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Novavax, Inc. (2019-2024)
Table 110. Novavax, Inc. Recent Developments
Table 111. Sanofi Pasteur Basic Information List
Table 112. Sanofi Pasteur Description and Business Overview
Table 113. Sanofi Pasteur COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 114. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Sanofi Pasteur (2019-2024)
Table 115. Sanofi Pasteur Recent Developments
Table 116. Baylor Basic Information List
Table 117. Baylor Description and Business Overview
Table 118. Baylor COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 119. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Baylor (2019-2024)
Table 120. Baylor Recent Developments
Table 121. iBio, Inc. Basic Information List
Table 122. iBio, Inc. Description and Business Overview
Table 123. iBio, Inc. COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 124. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of iBio, Inc. (2019-2024)
Table 125. iBio, Inc. Recent Developments
Table 126. Moderna, Inc. Basic Information List
Table 127. Moderna, Inc. Description and Business Overview
Table 128. Moderna, Inc. COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 129. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Moderna, Inc. (2019-2024)
Table 130. Moderna, Inc. Recent Developments
Table 131. Curevac Basic Information List
Table 132. Curevac Description and Business Overview
Table 133. Curevac COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 134. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of Curevac (2019-2024)
Table 135. Curevac Recent Developments
Table 136. ImmunoPrecise Basic Information List
Table 137. ImmunoPrecise Description and Business Overview
Table 138. ImmunoPrecise COVID-19 Inactivated Vaccine Products, Services and Solutions
Table 139. Revenue (US$ Million) in COVID-19 Inactivated Vaccine Business of ImmunoPrecise (2019-2024)
Table 140. ImmunoPrecise Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. COVID-19 Inactivated Vaccine Downstream Customers
Table 144. COVID-19 Inactivated Vaccine Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
Table 148. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. COVID-19 Inactivated Vaccine Product Picture
Figure 2. Global COVID-19 Inactivated Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global COVID-19 Inactivated Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. COVID-19 Inactivated Vaccine Report Years Considered
Figure 5. Global COVID-19 Inactivated Vaccine Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by COVID-19 Inactivated Vaccine Revenue in 2023
Figure 7. COVID-19 Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. In Clinical Trials Picture
Figure 9. Out-of-Clinical Trials Picture
Figure 10. Global COVID-19 Inactivated Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global COVID-19 Inactivated Vaccine Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Hospital
Figure 13. Product Picture of Clinic
Figure 14. Product Picture of Other
Figure 15. Global COVID-19 Inactivated Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global COVID-19 Inactivated Vaccine Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America COVID-19 Inactivated Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 18. North America COVID-19 Inactivated Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe COVID-19 Inactivated Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe COVID-19 Inactivated Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific COVID-19 Inactivated Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific COVID-19 Inactivated Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 23. South America COVID-19 Inactivated Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 24. South America COVID-19 Inactivated Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa COVID-19 Inactivated Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa COVID-19 Inactivated Vaccine Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions COVID-19 Inactivated Vaccine Sales Value (%), (2019-2030)
Figure 28. United States COVID-19 Inactivated Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States COVID-19 Inactivated Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 30. United States COVID-19 Inactivated Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe COVID-19 Inactivated Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe COVID-19 Inactivated Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe COVID-19 Inactivated Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 34. China COVID-19 Inactivated Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 35. China COVID-19 Inactivated Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 36. China COVID-19 Inactivated Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan COVID-19 Inactivated Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan COVID-19 Inactivated Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan COVID-19 Inactivated Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea COVID-19 Inactivated Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea COVID-19 Inactivated Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea COVID-19 Inactivated Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia COVID-19 Inactivated Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia COVID-19 Inactivated Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia COVID-19 Inactivated Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 46. India COVID-19 Inactivated Vaccine Sales Value, (2019-2030) & (US$ Million)
Figure 47. India COVID-19 Inactivated Vaccine Sales Value by Type (%), 2023 VS 2030
Figure 48. India COVID-19 Inactivated Vaccine Sales Value by Application (%), 2023 VS 2030
Figure 49. COVID-19 Inactivated Vaccine Industrial Chain
Figure 50. COVID-19 Inactivated Vaccine Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
